FENNEC PHARMACEUTICALS INC. (FENC) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $193.19M; Additional Paid in Capital, Common StockUSD $75.26M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.24M; Retained Earnings (Accumulated Deficit)USD $-227.25M.
- 2026-03-31: Common Stock, Value, IssuedUSD $191.23M; Additional Paid in Capital, Common StockUSD $74.42M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.24M; Retained Earnings (Accumulated Deficit)USD $-229.22M.
- 2025-12-31: Common Stock, Value, IssuedUSD $189.91M; Additional Paid in Capital, Common StockUSD $73.75M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.24M; Retained Earnings (Accumulated Deficit)USD $-229.42M.
- 2025-09-30: Common Stock, Value, IssuedUSD $147.65M; Additional Paid in Capital, Common StockUSD $71.25M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.24M; Retained Earnings (Accumulated Deficit)USD $-224.64M.
FENNEC PHARMACEUTICALS INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Common Stock, Value, Outstanding USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Recognition and Exercise USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $193.19M | $75.26M | $1.24M | $-227.25M | $42.44M | $2.00K | 3 month · $1.71M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $191.23M | $74.42M | $1.24M | $-229.22M | $37.67M | (m) | 3 month · $990.00K | 3 month · $990.00K | (m) | (m) | (m) | (m) |
| 2025-12-31 | $189.91M | $73.75M | $1.24M | $-229.42M | $35.47M | $2.00K | 12 month · $7.03M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $147.65M | $71.25M | $1.24M | $-224.64M | $-4.49M | $1.00K | (m) | 3 month · $2.22M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $146.16M | $69.13M | $1.24M | $-224.00M | $-7.46M | $1.00K | (m) | 3 month · $1.49M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $145.98M | $67.74M | $1.24M | $-220.85M | $-5.88M | (m) | 3 month · $798.00K | 3 month · $798.00K | (m) | (m) | (m) | (m) |
| 2024-12-31 | $145.61M | $66.96M | $1.24M | $-219.68M | $-5.87M | $2.00K | 12 month · $5.06M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $145.44M | $65.84M | $1.24M | $-217.70M | $-5.17M | $2.00K | (m) | 3 month · $1.82M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $145.28M | $64.08M | $1.24M | $-211.96M | $-1.36M | $6.00K | (m) | 3 month · $925.00K | (m) | (m) | (m) | (m) |
| 2024-03-31 | $144.93M | $63.24M | $1.24M | $-206.41M | $3.01M | $4.00K | (m) | 3 month · $1.19M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $144.31M | $62.07M | $1.24M | $-219.25M | $-11.62M | $17.00K | 12 month · $5.35M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $143.56M | $61.23M | $1.24M | $215.61M | $-10.53M | $13.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $143.34M | $60.38M | $1.24M | $-214.70M | $-9.73M | $25.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $142.80M | $57.87M | $1.24M | $-209.25M | $-7.34M | $25.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $142.59M | $56.80M | $1.24M | $-203.20M | $-2.57M | $56.00K | (m) | (m) | 12 month · $862.00K | (m) | 12 month · $441.00K | (m) |
| 2022-09-30 | $141.31M | $56.59M | $1.24M | $-196.34M | $2.80M | $114.00K | (m) | (m) | (m) | (m) | 3 month · $441.00K | (m) |
| 2022-06-30 | $140.92M | $54.63M | $1.24M | $-188.25M | $8.54M | $148.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $140.83M | $53.63M | $1.24M | $-183.18M | $12.52M | $148.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $140.80M | $53.21M | $1.24M | $-179.49M | $15.77M | $240.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $140.78M | $52.05M | $1.24M | $-175.06M | $19.01M | $402.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $140.78M | $51.13M | $1.24M | $-170.87M | $22.28M | $327.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $140.73M | $49.83M | $1.24M | $-166.87M | $24.93M | $182.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $140.73M | $49.23M | $1.24M | $-162.14M | $29.07M | $265.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $139.73M | $49.11M | $1.24M | $-158.90M | $31.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $138.36M | $49.23M | $1.24M | $-152.70M | $36.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $106.39M | $48.68M | $1.24M | $-147.86M | $8.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $106.39M | $48.27M | $1.24M | $-144.03M | $11.88M | (m) | (m) | (m) | (m) | (m) | 12 month · $255.00K | (m) |
| 2019-09-30 | $106.39M | $47.79M | $1.24M | $-140.42M | $15.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $106.39M | $47.45M | $1.24M | $-138.61M | $16.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $106.39M | $45.45M | $1.24M | $-133.88M | $19.21M | (m) | (m) | (m) | (m) | (m) | 3 month · $255.00K | (m) |
| 2018-12-31 | $106.39M | $44.93M | $1.24M | $-131.26M | $21.31M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $18.00K |
| 2018-09-30 | $104.77M | $45.12M | $1.24M | $-128.27M | $22.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $104.01M | $45.13M | $1.24M | $-125.52M | $24.86M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $18.00K |
| 2018-03-31 | $103.34M | $44.02M | $1.24M | $-122.94M | $25.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $103.05M | $43.84M | $1.24M | $-121.37M | $26.76M | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) |
| 2017-09-30 | $83.06M | $43.63M | $1.24M | $-119.08M | $8.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $82.28M | $42.88M | $1.24M | $-116.73M | $9.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $74.52M | $42.23M | $1.24M | $-115.13M | $2.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $74.52M | $42.13M | $1.24M | $-114.32M | $3.57M | (m) | (m) | (m) | (m) | (m) | 3 month · $23.00K 12 month · $72.00K | (m) |
| 2016-09-30 | $74.26M | $41.90M | $1.24M | $-113.18M | $4.22M | (m) | 3 month · $41.00K | (m) | (m) | (m) | 3 month · $19.00K | (m) |
| 2016-06-30 | $74.26M | $41.83M | $1.24M | $113.18M | $4.65M | (m) | 3 month · $111.00K | (m) | (m) | (m) | 3 month · $17.00K | (m) |
| 2016-03-31 | $69.25M | $41.70M | $1.24M | $-111.95M | $243.00K | (m) | (m) | (m) | (m) | (m) | 3 month · $13.00K | (m) |
| 2015-12-31 | $69.40M | $41.44M | $1.24M | $-111.53M | $548.00K | (m) | 3 month · $69.00K 12 month · $97.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $69.15M | $41.62M | $1.24M | $-110.99M | $1.02M | (m) | 3 month · $9.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $69.13M | $41.61M | $1.24M | $-110.87M | $1.11M | (m) | 3 month · $10.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $68.68M | $41.60M | $1.24M | $-110.70M | $826.00K | (m) | 3 month · $9.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $68.66M | $41.59M | $1.24M | $-110.87M | $613.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $66.79M | $41.00M | $1.24M | (m) | $-3.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $66.79M | $39.95M | $1.24M | (m) | $-4.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $66.79M | $39.52M | $1.24M | (m) | $-4.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $66.79M | $39.21M | $1.24M | $-108.70M | $-1.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $65.95M | $38.49M | $1.24M | (m) | $-4.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $65.95M | $38.42M | $1.24M | (m) | $-2.43M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $65.95M | $38.39M | $1.24M | (m) | $-9.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $65.95M | $38.39M | $1.24M | (m) | $-4.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $65.95M | $38.12M | $1.24M | (m) | $1.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $65.95M | $38.12M | $1.24M | (m) | $2.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $65.95M | $38.06M | $1.24M | (m) | $2.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $65.95M | $38.06M | $1.24M | (m) | $-120.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $65.95M | $38.02M | $1.24M | (m) | $-3.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $65.95M | $37.86M | $1.24M | (m) | $-684.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | $-283.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $64.93M | $37.72M | $1.24M | (m) | $-4.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | $406.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | $3.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | (m) | (m) | $14.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | (m) | (m) | $1.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2005-12-31 | (m) | (m) | (m) | (m) | $11.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2004-12-31 | (m) | (m) | (m) | (m) | $16.65M | (m) | (m) | (m) | 6 month · $493.00K | (m) | (m) | (m) |
| 2004-06-30 | (m) | (m) | (m) | (m) | $20.45M | (m) | (m) | (m) | (m) | 12 month · $1.98M | (m) | 12 month · $18.00K |
| 2003-06-30 | (m) | (m) | (m) | (m) | $698.00K | (m) | (m) | (m) | (m) | 12 month · $1.06M | 12 month · $53.00K | (m) |
| 2002-06-30 | (m) | (m) | (m) | (m) | $6.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2001-06-30 | (m) | (m) | (m) | (m) | $9.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2000-06-30 | (m) | (m) | (m) | (m) | $47.00K | (m) | (m) | (m) | (m) | (m) | 12 month · $255.00K | (m) |
| 1999-06-30 | (m) | (m) | (m) | (m) | $242.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 1998-06-30 | (m) | (m) | (m) | (m) | $-435.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 1997-06-30 | (m) | (m) | (m) | (m) | $-37.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 1997-06-23 | (m) | (m) | (m) | (m) | $-37.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 1996-09-02 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 1996-06-30 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |